COMMISSION DELEGATED REGULATION (EU) 2021/1456
of 2 June 2021
supplementing Regulation (EU) No 648/2012 of the European Parliament and of the Council by specifying the conditions under which the commercial terms for clearing services for OTC derivatives are to be considered to be fair, reasonable, non-discriminatory and transparent
(Text with EEA relevance)
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EU) No 648/2012 of the European Parliament and of the Council of 4 July 2012 on OTC derivatives, central counterparties and trade repositories 1, and in particular Article 4(3a), third subparagraph, thereof,
Whereas:
HAS ADOPTED THIS REGULATION: